Search hospitals > Kansas > Newton
Cancer Center of Kansas - Newton
Claim this profileNewton, Kansas 67114
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
387 reported clinical trials
9 medical researchers
Summary
Cancer Center of Kansas - Newton is a medical facility located in Newton, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Cancer Center of Kansas - Newton is involved with conducting 387 clinical trials across 423 conditions. There are 9 research doctors associated with this hospital, such as Shaker Dakhil, M.D., Dennis F. Moore, Eric Whitman, MD, and Charles M Farber, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
ER negative
2Lung Cancer
Global LeaderStage II
Stage I
Stage IV
Top PIs
Shaker Dakhil, M.D.Ascension Via Christi Hospitals Wichita6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
83 reported clinical trials
170 drugs studied
Dennis F. MooreAscension Via Christi Hospitals Wichita4 years of reported clinical research
Studies Lung Cancer
Studies Breast Cancer
30 reported clinical trials
80 drugs studied
Eric Whitman, MDMorristown Medical Center8 years of reported clinical research
Expert in Melanoma
Expert in Cancer
24 reported clinical trials
57 drugs studied
Charles M Farber, MDMorristown Medical Center13 years of reported clinical research
Studies Lung Cancer
Studies Lymphoma
19 reported clinical trials
39 drugs studied
Clinical Trials running at Cancer Center of Kansas - Newton
Lung Cancer
Breast Cancer
Bladder Cancer
Breast cancer
Prostate Cancer
Bladder Carcinoma
Ovarian Cancer
Multiple Myeloma
Colorectal Cancer
Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting2 awards Phase 310 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Center of Kansas - Newton?
Cancer Center of Kansas - Newton is a medical facility located in Newton, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Cancer Center of Kansas - Newton is involved with conducting 387 clinical trials across 423 conditions. There are 9 research doctors associated with this hospital, such as Shaker Dakhil, M.D., Dennis F. Moore, Eric Whitman, MD, and Charles M Farber, MD.
Where is Cancer Center of Kansas - Newton located?
The Cancer Center of Kansas, Newton, is located at 720 Medical Center Drive, Newton, KS 67114.
Who should I call to ask about financial aid or insurance network?
To contact the Cancer Center of Kansas - Newton, call (316) 262-4467 or visit <https://cancercenterofkansas.com>. For appointments, use the same number. For patient portal access, dial 316-262-4467 and enter extension 6161 upon hearing the recording. Specific contact details for each location are available on their website.
What insurance does Cancer Center of Kansas - Newton accept?
The Cancer Center of Kansas - Newton accepts a wide range of insurances, including Original Medicare (Parts A & B), Medicare Advantage (Part C) HMO plans, and commercial insurance plans such as Aetna Commercial, BCBS Commercial, Cigna, and Humana Commercial. It is important to verify with your insurance company that the Cancer Center of Kansas - Newton is in-network for your specific plan.
What awards or recognition has Cancer Center of Kansas - Newton received?
The Cancer Center of Kansas, located in Newton, Kansas, is renowned for its high-quality and innovative cancer care. It is part of a distinguished network that was named the Favorite Cancer Center of Kansas in the Wichita Kansas Reader's Choice Awards in 2016 and 2018. This network is also recognized for establishing the first community-based nationally recognized research program in 1983 through the National Cancer Institute (NCI).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.